Wolverine Trading, LLC Ligand Pharmaceuticals Inc Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $123,961 - $197,785	-1,305 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$127.69 - $165.85 $166,635 - $216,434	1,305 New	1,305 $204,000
Q1 2020 May 11, 2020	SELL	$63.37 - $107.88 $328,573 - $559,357	-5,185 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$96.94 - $113.59 $742,657 - $870,212	-7,661 Reduced 59.64%	5,185 $539,000
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $260,647 - $363,123	-3,022 Reduced 19.04%	12,846 $1.27 Million
Q2 2019 Aug 20, 2019	SELL	$107.38 - $129.34 $1.94 Million - $2.33 Million	-18,028 Reduced 53.19%	15,868 $1.81 Million
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $1.98 Million - $2.66 Million	18,675 Added 122.69%	33,896 $4.26 Million
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $1.95 Million - $4.14 Million	15,221 New	15,221 $2.07 Million

256

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.79B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.